Business Development Committee

The Mission

To build relationships between and among BioNJ Members focused on business development and the New Jersey life sciences ecosystem to ensure that collaborations are created and drugs, diagnostics, devices and related technologies are developed.

The Vision

A highly networked ecosystem created through BioNJ initiatives where business development professionals are supported and interconnected to foster drug, diagnostic, device and related technology development in New Jersey.

Committee Members

Lynn Croucher, Senior Director, Business Development, Bristol-Myers Squibb Company
Pamela Demain, Executive Director, Business Development & Licensing, Merck & Co., Inc.
Arial Jasie, Senior Director, Business Development, Celgene Corporation
Sam Kongsamut, Ph.D., Owner and Principal, Rudder Serendip LLC
John Krayacich
, Vice President & Head, Planning & Business Development & Licensing, Novartis Pharmaceuticals Corporation
Scott Megaffin, President, Churchill Pharmaceuticals LLC
Denis Segota, Partner, Morgan, Lewis & Bockius, LLP
Arda Ural, Ph.D., Partner, Ernst & Young
Drayton Wise, Senior Director, Commercial Operations & Marketing, Insmed Inc.